Delivery Order SPE2DR25D2212-SPE2DR26FB9JS
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,048.28 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,981.41 on November 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $9,096.42 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract is classified as a firm fixed price delivery order with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order represents...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,405.80 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on September 24, 2025, with completion expected by September 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,553.22 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This non-competitive delivery order was issued on May 30, 2025, with an ultimate completion date of June 2, 2025, and reflects a firm fixed-price contract structure. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,893.22 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract issued as a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,661.40 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This contract represents a competitive, non-set-aside award under a firm fixed-price arrangement with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $9.8K delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with completion scheduled for December 3, 2025. This competitive, non-set-aside award reflects a firm fixed price contract structure and represents a single delivery order fulfillment under AmerisourceBergen's existing pharmaceutical supply relationship with the federal government. The place of performance is located at...
- The Defense Logistics Agency awarded a delivery order valued at $4,711.09 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and identifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single transaction...